Acne Vulgaris: Establishing Effectiveness of Drugs Intended for Treatment
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 22, 2018
April 21, 2020
513aaac8-5cc8-4e47-8797-621cd7679a08
Related Documents
Allergic Rhinitis: Developing Drug Products for Treatment Guidance for Industry
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Nonallergic Rhinitis: Developing Drug Products for Treatment
Guidance DocumentSeptember 6, 2018Center for Drug Evaluation and Research
Migraine: Developing Drugs for Acute Treatment
Guidance DocumentFebruary 16, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.